impact of costs related to the license agreement, known and unknown, including costs of any litigation or regulatory actions relating to the license agreement
Suspected adverse reactions should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study
Wegovy and Zepbound, which both sell for a list price of more than $1,000 a month, have long been out of reach for people without insurance or whose insurance refused to cover them
GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study
Once retatrutide becomes available, it should only be purchased through legitimate, certified online pharmacies or your healthcare provider